z-logo
open-access-imgOpen Access
Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
Author(s) -
Ilan Youngster,
Jenny Sauk,
Christina Pindar,
Robin Wilson,
Jess L. Kaplan,
Mark Smith,
Eric J. Alm,
Dirk Gevers,
George H. Russell,
Elizabeth Hohmann
Publication year - 2014
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciu135
Subject(s) - medicine , interquartile range , clostridium difficile , clinical endpoint , colonoscopy , diarrhea , surgery , adverse effect , randomized controlled trial , feces , gastroenterology , antibiotics , colorectal cancer , cancer , microbiology and biotechnology , biology , paleontology
Recurrent Clostridium difficile infection (CDI) with poor response to standard antimicrobial therapy is a growing medical concern. We aimed to investigate the outcomes of fecal microbiota transplant (FMT) for relapsing CDI using a frozen suspension from unrelated donors, comparing colonoscopic and nasogastric tube (NGT) administration.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom